REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Wuxi Xdc Cayman Inc. (China)

Main Activities: Research and Development in Nanotechnology
Secondary Activities: Biological Product (except Diagnostic) Manufacturing
Full name: Wuxi Xdc Cayman Inc. Profile Updated: October 23, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Chinese Download a sample report

WuXi XDC Cayman Inc is engaged in the provision of comprehensive contract research, development and manufacturing organization (CRDMO) services for antibody drug conjugate (ADC) and other bioconjugates. The company was established in 2020 and is headquartered in Wuxi City, Jiangsu Province.

Headquarters
No. 11 Xinhui Ring Road, Xinwu District
Wuxi; Jiangsu;

Contact Details: Purchase the Wuxi Xdc Cayman Inc. report to view the information.

Website: http://www.wuxixdc.com

Basic Information
Total Employees:
Purchase the Wuxi Xdc Cayman Inc. report to view the information.
Outstanding Shares:
Purchase the Wuxi Xdc Cayman Inc. report to view the information.
Financial Auditors:
Purchase the Wuxi Xdc Cayman Inc. report to view the information.
Incorporation Date:
December 10, 2025
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Chief Financial Officer
Purchase this report to view the information.
Chief Operating Officer
Purchase this report to view the information.
Director/Member of the Board
Ownership Details
Purchase this report to view the information.
50.95%
Purchase this report to view the information.
30.33%
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Wuxi Xdc Hong Kong Limited (Hong Kong SAR, China)
100%
Company Performance
Financial values in the chart are available after Wuxi Xdc Cayman Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
62.19%▲
Total operating revenue
61.61%▲
Operating profit (EBIT)
92.43%▲
EBITDA
86.85%▲
Net Profit (Loss) for the Period
52.74%▲
Total assets
46.12%▲
Total equity
24.23%▲
Operating Profit Margin (ROS)
4.75%▲
Net Profit Margin
-1.71%▼
Return on Equity (ROE)
1.87%▲
Debt to Equity Ratio
12.81%▲
Quick Ratio
-1.88%▼
Cash Ratio
-1.54%▼

Similar companies

Shenzhen Dynanonic Co.,Ltd.
 
Beijing Health Guard Biotechnology Inc.

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo